About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Arhgef10tm1.1Ssfg
targeted mutation 1.1, Susan Shur-Fen Gau
MGI:6287205
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Arhgef10tm1.1Ssfg/Arhgef10tm1.1Ssfg B6.129S1-Arhgef10tm1.1Ssfg MGI:6287207


Genotype
MGI:6287207
hm1
Allelic
Composition
Arhgef10tm1.1Ssfg/Arhgef10tm1.1Ssfg
Genetic
Background
B6.129S1-Arhgef10tm1.1Ssfg
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Arhgef10tm1.1Ssfg mutation (0 available); any Arhgef10 mutation (69 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
N
• mice have a normal startle reflex response and show normal spatial learning in the Morris water maze test and no obvious impulsive behaviors in the electro-foot shock aversive water drinking test (EFSDT)
• in the tail suspension and forced swim tests, mice exhibit significantly decreased immobility time relative to wild-type controls, indicating reduced depression-related behavior
• in the elevated plus maze test, mice spend significantly more time in the open arms than wild-type controls, indicating reduced anxiety-like behavior
• in the open field test, mice show significantly increased spontaneous locomotor activity relative to wild-type controls
• however, rearing activity and percent of activity in the center of the open field are normal
• in the 3-chamber paradigm, mice exhibit social impairment, as they fail to spend a significantly longer time in the chamber with a stranger mouse 1 than in the empty chamber and show equal active interaction time in the chamber with the empty cylinder and stranger 1, unlike wild-type controls
• in the preference for social novelty test, mice spend less time in the chamber with a novel mouse stranger 2 than in the chamber with stranger 1 and the time spent in social interactions is similar between the stranger mouse 1 and 2, unlike in wild-type controls

homeostasis/metabolism
• mice show significantly increased dopamine levels in the striatum and amygdala
• however, 3,4-Dihydroxyphenylacetic acid (DOPAC) levels are normal
• mice show significantly increased norepinephrine (NE) levels in the frontal cortex and amygdala
• mice show significantly increased serotonin (5-HT) levels in the frontal cortex and amygdala
• however, 5-hydroxyindoleacetic acid (5-HIAA) levels are normal
• protein levels of monoamine oxidase A (MAO-A) are significantly decreased in the frontal cortex and amygdala

nervous system
N
• mice exhibit no deficit in pre-pulse inhibition (PPI) relative to wild-type controls

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
autism spectrum disorder DOID:0060041 J:271943





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory